Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,342 | 257 | 93.1% |
| Education | $320.46 | 10 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $796.18 | 47 | $0 (2024) |
| Genentech USA, Inc. | $647.51 | 24 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $625.86 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $404.75 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $371.04 | 25 | $0 (2024) |
| Insmed, Inc. | $368.02 | 16 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $340.40 | 26 | $0 (2018) |
| Grifols USA, LLC | $143.43 | 10 | $0 (2021) |
| GENZYME CORPORATION | $140.90 | 7 | $0 (2024) |
| Mylan Specialty L.P. | $109.38 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.47 | 28 | Actelion Pharmaceuticals US, Inc. ($174.55) |
| 2023 | $626.74 | 33 | GlaxoSmithKline, LLC. ($100.47) |
| 2022 | $357.03 | 23 | GlaxoSmithKline, LLC. ($123.60) |
| 2021 | $266.63 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($70.39) |
| 2020 | $508.50 | 26 | Insmed, Inc. ($201.82) |
| 2019 | $877.75 | 39 | Genentech USA, Inc. ($314.81) |
| 2018 | $751.86 | 50 | Genentech USA, Inc. ($265.09) |
| 2017 | $798.19 | 53 | Sunovion Pharmaceuticals Inc. ($195.54) |
All Payment Transactions
267 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Cardiology | ||||||
| 08/14/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiology | ||||||
| 07/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiology | ||||||
| 06/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiology | ||||||
| 05/28/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardiology | ||||||
| 05/04/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Sleep | ||||||
| 04/17/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Narcoplepsy | ||||||
| 04/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiology | ||||||
| 03/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Cardiology | ||||||
| 03/22/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiology | ||||||
| 02/23/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $19.50 | General |
| 02/22/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Respiratory | ||||||
| 02/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiology | ||||||
| 02/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: VACCINES | ||||||
| 02/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Immunology | ||||||
| 01/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Cardio-pulmonary | ||||||
| 01/31/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiology | ||||||
| 01/22/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 952 | 1,210 | $214,007 | $77,864 |
| 2022 | 25 | 1,088 | 1,385 | $249,508 | $86,802 |
| 2021 | 22 | 1,145 | 1,587 | $305,632 | $110,290 |
| 2020 | 30 | 1,350 | 1,723 | $333,104 | $117,559 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 124 | 253 | $48,070 | $22,729 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 124 | $24,800 | $10,393 | 41.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 42 | 50 | $20,250 | $7,917 | 39.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 124 | $16,120 | $7,255 | 45.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 47 | $16,450 | $6,157 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 96 | $12,960 | $5,633 | 43.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $10,980 | $4,416 | 40.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 62 | 69 | $9,660 | $2,640 | 27.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 95 | 103 | $10,300 | $2,546 | 24.7% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 26 | 27 | $13,500 | $1,853 | 13.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,400 | $1,306 | 38.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 63 | 66 | $7,590 | $1,297 | 17.1% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 12 | 12 | $5,400 | $1,276 | 23.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 21 | 21 | $3,045 | $570.57 | 18.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 54 | $540.00 | $453.60 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $420.00 | $392.70 | 93.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 11 | 11 | $1,265 | $338.36 | 26.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 25 | 25 | $3,567 | $192.25 | 5.4% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 20 | 20 | $1,538 | $179.80 | 11.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 24 | 24 | $2,452 | $159.60 | 6.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 17 | 17 | $1,700 | $159.12 | 9.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 135 | 273 | $51,870 | $20,931 | 40.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 152 | 227 | $29,510 | $12,203 | 41.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 68 | $23,800 | $10,032 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 108 | $21,600 | $9,632 | 44.6% |
About Dr. Yadana Kyaw, MD
Dr. Yadana Kyaw, MD is a Critical Care Medicine healthcare provider based in Southaven, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134393473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yadana Kyaw, MD has received a total of $4,662 in payments from pharmaceutical and medical device companies, with $475.47 received in 2024. These payments were reported across 267 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,342).
As a Medicare-enrolled provider, Kyaw has provided services to 4,535 Medicare beneficiaries, totaling 5,905 services with total Medicare billing of $392,515. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Southaven, MS
- Active Since 04/17/2008
- Last Updated 03/28/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1134393473
Products in Payments
- Arikayce (Drug) $351.78
- TRELEGY ELLIPTA (Drug) $346.53
- UPTRAVI (Drug) $291.33
- OFEV (Drug) $252.79
- Xolair (Biological) $245.67
- OPSUMIT (Drug) $231.36
- NUCALA (Biological) $187.36
- UTIBRON (Drug) $176.44
- Esbriet (Biological) $163.59
- DUPIXENT (Biological) $140.90
- Utibron (Drug) $136.00
- OPSUMIT MACITENTAN (Drug) $103.17
- STIOLTO (Drug) $102.12
- Prolastin-C Liquid (Biological) $94.89
- SYMBICORT (Drug) $89.40
- WAKIX (Drug) $87.23
- GIAPREZA (Drug) $79.31
- ANORO (Drug) $72.70
- TEZSPIRE (Biological) $69.35
- XOLAIR (Biological) $64.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Southaven
Dr. Todd Henderson, Md, MD
Critical Care Medicine — Payments: $7,112
Istvan Wollak, M.d, M.D
Critical Care Medicine — Payments: $5,668
Sanjay Ratnakant, M.d, M.D
Critical Care Medicine — Payments: $3,688
John Walker, Crna, CRNA
Critical Care Medicine